Form EFFECT PALISADE BIO, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 28, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
- Tissue Heart Valves Market to Reach USD 25,307.93 Million by 2034, Driven by Rising Valvular Heart Disease Cases, TAVR Expansion, and Technological Advancements
- Polygon Price Prediction: POL Traders Watch $0.155 as Remittix Reveals Its RTX Launch Date
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
